VYJUVEK (Krystal Biotech) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Krystal Biotech, Inc. (KRYS)
Last krystal biotech, inc. earnings: 11/4 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.krystalbio.com/investors
Company Research
Source: Yahoo! Finance
treatments, increased investments in topical gene delivery technologies, and advancements in redosable therapy platforms, all amid rising chronic disease prevalence. Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "VYJUVEK Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Vyjuvek market is experiencing significant growth driven by advancements in gene delivery technologies, emerging topical therapies, and increasing prevalence of chronic conditions. These developments, alongside regulatory support and innovations in redosable therapy platforms, are shaping the future of gene therapies in dermatology, particularly in treating rare genetic disorders. The ongoing research and breakthroughs in gene delivery vectors have expanded the scope of dermatological gene therapies, with topical solutions showing early success in clinical trials. The focus on rare genetic skin disorders is elevating the dem
Show less
Read more
Impact Snapshot
Event Time:
KRYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRYS alerts
High impacting Krystal Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
KRYS
News
- Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224 [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech (KRYS) had its price target raised by Guggenheim from $224.00 to $284.00. They now have a "buy" rating on the stock.MarketBeat
- Krystal Biotech to Present at TD Cowen 46th Annual Health Care ConferenceGlobeNewswire
- Krystal Biotech's KB707 RMAT Win Opens New Lung Cancer Chapter [Yahoo! Finance]Yahoo! Finance
- Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 [Yahoo! Finance]Yahoo! Finance
KRYS
Earnings
- 2/17/26 - Beat
KRYS
Sec Filings
- 3/6/26 - Form 3
- 3/6/26 - Form 3
- 3/6/26 - Form 4
- KRYS's page on the SEC website